您要查找的是不是:
- Fosinopril (MoNopril) is an ester pro-drug of the active Daicel fosinoprilat and is the first member of a new class of angiotensin-converting enzyme (ACE) inhibitors, the phosphoric acids. 福辛普利(蒙诺)是其活性二价酸福辛普利拉的酯类前体药物,也是新的磷酸类血管紧张素转换酶(ACE)抑制剂家族中的第一个成员。
- The first 3 places of DDDs of antihypertensive drugs were Felodipine, monopril and losartan. 限定日剂量数排序前3位是非洛地平、福辛普利钠和氯沙坦;
- The two drugs could decrease EDT(P < 0. 05) and carvedilol was slightly stronger than fosinopril(P< 0.05). 两者均能降低EDT(P<0.;05);卡维地洛较福辛普利作用略强(P<0
- Abstract Objective To investigate the for Fosinopril essential hypertension in patients with heart rate variability. 目的探讨福辛普利对原发性高血压患者心率变异性的影响。
- After 4 weeks of fosinopril treatment, ET level in EH decreased significantly with the reduction of blood pressure. 福辛普利治疗4周后,随血压下降,内皮素浓度亦明显降低。
- Objectives To compare the clinical efficacy of fosinopril and captopril in treatment of hypertensin. 目的比较福辛普利与卡托普利治疗高血压的临床疗效。
- The same interaction could occur with other widely prescribed heart and blood-pressure drugs - known as ACE inhibitors - such as Accupril, Prinivil and Monopril. 同样的相互作用也会见诸其它被广泛开出治疗心脏与血压病的药物--通常称为ACE抑制药--诸如阿克普瑞,赖诺普利和福辛普利。
- The trough to peak ratios were calculated as 59.9% for fosinopril and 47.1% for enalapril. 福辛普利降压谷峰值比率59.;9%25,依那普利为47
- Objective To investigate the effects of fosinopril and nifedipineon urinary albumin excretion and kidney function. 目的观察比较福辛普利和硝苯地平对老年高血压患者白蛋白尿及肾功能的疗效。
- New generation of ACEI, for example Monopril, can not only lower the blood pressure, but also reduce the risk of cardiovascular event and death.Meanwhile, it protects the kidney. 新一代ACEI,如蒙诺,不仅能帮助降压达标,还能降低心血管事件和死亡的风险,并保护肾脏。
- Fosinopril in the conclusion of the step-down at the same time, improve essential hypertension in patients with heart rate variability. 结论福辛普利在降压的同时,可改善原发性高血压患者的心率变异性。
- Methods The plasma ET levels were measured in 52 old EH and 25 old healthy subjects, the formers were measured again after fosinopril treatment. 方法测定52例老年EH患者和25例健康老年人血浆内皮素浓度,并对EH组予福辛普利治疗4周后复测内皮素。
- The antihypertensive efficacy of Imidapril was better than that of Fosinopril at the fourth week and eighth week (P<0.01). 在8周时咪达普利组在降收缩压上优于福辛普利组(P<0.;01),但在降舒张压上两组之间差异无统计学意义(P>0
- Objective To compare the cough occurrence and the antihypertensive efficacy of Imidapril versus Fosinopril in patients with essential hypertension. 摘要目的比较高血压患者应用咪达普利或福辛普利的咳嗽发生率以及降压疗效。
- METHODS:186 patients with essential hypertension were randomly divided into three groups receiving enalapril,fosinopril and perindopril respectively. 方法:选择186例原发性高血压患者,随机分为3组,分别给予依那普利、福辛普利、培哚普利,运用药物经济学方法进行分析。
- Objective To compare the efficacy and safety of fosinopril and enalapril in the treatment of mild to moderate hypertension. 目的比较福辛普利与依那普利治疗轻中度高血压病的疗效和安全性。
- Objective To observation the effects of fosinopril plus carvedilo in the treating patients with congestive heart failure(CHF). 目的:观察福辛普利和卡维地洛联合治疗慢性充血性心力衰竭(CHF)的临床疗效。
- Conclusion: Yiyuanbaoshen decoction combined with fosinopril is effective in treating early type2 diabetic nephropathy with deficiency of Qi and Yin with blood stasis syndrome. 结论:益元保肾方配合福辛普利是治疗气阴两虚夹瘀型早期2型糖尿病肾病的有效方法。
- The significant decrease in LVW/BW,[Ca2+]i,and Pag were found in kudzuvine root group and fosinopril group,as compared with those in control group (P<0.01). 干预8周后;葛根素组、福辛普利组与NS组比较;均能显著降低左心室肥厚指数、血小板胞浆[Ca2+]i和Pag(P<0.;01)。
- After 24 hours Bcl-2 mRNA expression were lower,fosinopril enhanced its over expression,Bax, Fas, P53 mRNA expression were higher,fosinopril inhibited their expression. 急性心肌梗死24hBcl-2表达下降,福辛普利促进其高表达,Bax、P53、Fas增高,福辛普利抑制其表达;